注册 | 登录
点击这里给我发消息
所有产品
  • 所有产品
  • 一抗
  • 裂解液
>   首页   >   产品   >   一抗   >   其他   >   Anti-GPR64 / ADGRG2 Reference Antibody (Facet patent anti-GPR64)   

Anti-GPR64 / ADGRG2 Reference Antibody (Facet patent anti-GPR64)

     
  • 0 - Anti-GPR64 / ADGRG2 Reference Antibody (Facet patent anti-GPR64) APR11156
    Anti-GPR64 / ADGRG2 Reference Antibody (Facet patent anti-GPR64) on SDS-PAGE under reducing (R) condition. The purity of the protein is greater than 95%.
  • 0 - Anti-GPR64 / ADGRG2 Reference Antibody (Facet patent anti-GPR64) APR11156
    The purity of Anti-GPR64 / ADGRG2 Reference Antibody (Facet patent anti-GPR64) is 98.2%, determined by SEC-HPLC.
  • 0 - Anti-GPR64 / ADGRG2 Reference Antibody (Facet patent anti-GPR64) APR11156
    PLVX-puro-huADGRG2-his-P2A-EGFP cells were stained with Facet patent anti GPR64 and negative control protein respectively, washed and then followed by PE and analyzed with FACS, The EC50 is 3.797 nM.
  • 产品详情
  • 实验流程
Product Information
Application
  • Applications Legend:
  • E=ELISA
  • WB=Western Blotting
  • IHC=Immunohistochemistry
  • IHC-P=Immunohistochemistry (Paraffin)
  • IP=Immunoprecipitation
  • IF=Immunofluorescence
  • IC=Immunochemistry
  • ICC=Immunocytochemistry
  • FC=Flow Cytometry
  • DB=Dot Blot
Functional assay, Kinetics (SPR), Kinetics (BLI), FACS, E, FTA
Primary Accession Q8IZP9
Reactivity Human
Clonality Monoclonal
Isotype IgG
Calculated MW 111593 Da
Additional Information
Target/Specificity GPR64 / ADGRG2
Expression system CHO

For Research Use Only. Not For Use In Diagnostic Procedures.

Patent Notice: The variable region sequence of this antibody is derived from a published third-party patent. This product is manufactured independently as a Research Use Only (RUO) reagent and is not licensed, sponsored, or endorsed by the patent holder. It is intended solely for research purposes. Customers considering any commercial, diagnostic, or therapeutic use should independently evaluate freedom-to-operate with respect to relevant third-party patents.

Protein Information
Name ADGRG2 {ECO:0000303|PubMed:25713288, ECO:0000312|HGNC:HGNC:4516}
Function Adhesion G protein-coupled receptor (aGPCR) for steroid hormones, such as dehydroepiandrosterone (DHEA; also named 3beta- hydroxyandrost-5-en-17-one) and androstenedione (PubMed:29393851, PubMed:35982227, PubMed:39884271). Involved in a signal transduction pathway controlling epididymal function and male fertility (PubMed:29393851). Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of downstream effectors, such as adenylate cyclase (PubMed:33303626, PubMed:34234254). ADGRG2 is coupled to G(s) G proteins and mediates activation of adenylate cyclase activity (PubMed:29393851, PubMed:34234254). Also able to couple with G(q) G proteins in vitro (PubMed:29393851). Together with CFTR, required to promote fluid reabsorption within efferent ductule (PubMed:29393851).
Cellular Location Apical cell membrane; Multi-pass membrane protein
Tissue Location Epididymis-specific expression (at protein level). Both subunits are associated with apical membranes of efferent ductule and proximal epididymal duct epithelia. Mainly expressed in the nonciliated principal cells of the proximal excurrent ducts Specifically over-expressed in Ewing sarcomas but also up-regulated in a number of carcinomas derived from prostate, kidney or lung
Research Areas
FeedBack

终于等到您。ABCEPTA(百远生物)抗体产品。
点击下方“我要评价 ”按钮提交您的反馈信息,您的反馈和评价是我们最宝贵的财富之一,
我们将在1-3个工作日内处理您的反馈信息。

如有疑问,联系:0512-88856768 tech-china@abcepta.com.


我要评价